evbiotech

Internview

“When working at EV Biotech as an intern, you are really part of a team and your tasks are important. You are not just an intern” Currently, we have several student interns working at EV Biotech. With open intern vacancies snapped up as soon as they are posted, they will not be the last. What do these […]

Internview Read More »

Er garen bij spinnen

 Source: C2W magazine Puck Moll | donderdag 8 april 2021Materialen & Coatings De beloftes van spinzijde zijn groot: sterker, lichter en flexibeler dan staal, en tevens biocompatibel. Nederlandse en Vlaamse onderzoekers en ondernemers werken gestaag verder om dit kunstje van moeder natuur buiten de spin te herhalen. ‘AMSilk is vooralsnog het enige bedrijf dat op grotere schaal spinzijde weet

Er garen bij spinnen Read More »

Scouting international talent at MIT & Harvard with Elfsquad and EV Biotech

The MIT European Career Fair (ECF) in Boston is one of the biggest international career events, specifically focused on working in Europe. It’s a great way to meet and potentially recruit the best of the brightest, so Northern Dutch startups and scale-ups Elfsquad, EV Biotech and Vrroom were more than happy to drop by. We

Scouting international talent at MIT & Harvard with Elfsquad and EV Biotech Read More »

SG Papertronics B.V. and EV Biotech rose to the challenge and were rewarded with the MIT R&D subsidy.

Some good news to share. In the one year project, we will develop a glucose sensor for microbial fermentation. Thorough control over any process that involves living organisms is essential to its success. Therefore, having a chance to frequently check how much food for your microorganisms left is of the highest importance. The problem with frequent

SG Papertronics B.V. and EV Biotech rose to the challenge and were rewarded with the MIT R&D subsidy. Read More »

Nieuwe samenwerking Dig.Bio en EV Biotech

1 september j.l. hebben Digi.Bio en EV Biotech een nieuwe samenwerking aangekondigd voor het versnellen van de productie van cellijnen en therapeutica. “De bedrijven zetten hun gecombineerde expertise in digitale automatisering en geavanceerde modellerings- en genetische technieken in om de ontwikkeling van cellijnen te miniaturiseren en digitaliseren”, aldus Federico Muffatto, CEO van Digi.Bio. Tijdens de

Nieuwe samenwerking Dig.Bio en EV Biotech Read More »

Scroll to Top